中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
11期
86-87,90
,共3页
多药耐药%耐药性%抗菌药物
多藥耐藥%耐藥性%抗菌藥物
다약내약%내약성%항균약물
Multi-drug resistance%Resistance%Antibiotics
目的:了解乌鲁木齐头屯河地区多药耐药菌(MDROs)的临床分布及耐药性,为临床合理使用抗菌药物提供参考。方法回顾性分析2014年1月—2015年1月门诊及住院患者分离的MDROs的分布及耐药性,采用合肥恒星科技开发有限公司的HX-21细菌鉴定分析系统软件进行数据分析。结果共分离出215株MDROs,排在前三位的依次是产ESBLs大肠埃希菌、产ESBLs肺炎克雷伯菌、多药耐药鲍氏不动杆菌(MDRAB)。三种MDROs对氨苄西林耐药性均为100%,对头孢唑啉耐药性也均>94%。结论 MDROs对多种常用的抗生素耐药程度高,应加强患者多药耐药的检测,指导临床合理用药。
目的:瞭解烏魯木齊頭屯河地區多藥耐藥菌(MDROs)的臨床分佈及耐藥性,為臨床閤理使用抗菌藥物提供參攷。方法迴顧性分析2014年1月—2015年1月門診及住院患者分離的MDROs的分佈及耐藥性,採用閤肥恆星科技開髮有限公司的HX-21細菌鑒定分析繫統軟件進行數據分析。結果共分離齣215株MDROs,排在前三位的依次是產ESBLs大腸埃希菌、產ESBLs肺炎剋雷伯菌、多藥耐藥鮑氏不動桿菌(MDRAB)。三種MDROs對氨芐西林耐藥性均為100%,對頭孢唑啉耐藥性也均>94%。結論 MDROs對多種常用的抗生素耐藥程度高,應加彊患者多藥耐藥的檢測,指導臨床閤理用藥。
목적:료해오로목제두둔하지구다약내약균(MDROs)적림상분포급내약성,위림상합리사용항균약물제공삼고。방법회고성분석2014년1월—2015년1월문진급주원환자분리적MDROs적분포급내약성,채용합비항성과기개발유한공사적HX-21세균감정분석계통연건진행수거분석。결과공분리출215주MDROs,배재전삼위적의차시산ESBLs대장애희균、산ESBLs폐염극뢰백균、다약내약포씨불동간균(MDRAB)。삼충MDROs대안변서림내약성균위100%,대두포서람내약성야균>94%。결론 MDROs대다충상용적항생소내약정도고,응가강환자다약내약적검측,지도림상합리용약。
Objective To investigate the clinical distribution and drug resistance of the bacterial multi-drug resistance in Urumqi Toutun Riverarea (MDROs), to provide the reference for the clinical rational using antimicrobial agents.Methods Retrospective analysis of 2014 January to 2015 January distribution and drug resistance of separation of outpatients and hospitalized patients’ MDROs in a year, the HX-21 bacterial identification analysis system software which built by Hefei Star Technology Development Co. Ltd. Was used to analyze the data.Results A total of 215 strains of MDROs were isolated, the top three are ESBLs producing Escherichia coli,ESBLs producing Klebsiella pneumoniae, multi drug resistant Acinetobacter baumannii (MDRAB). Three kinds of MDROs were 100% for ampicillin resistance, resistanceto cefazolin were>94%.Conclusion MDROs has a high degree of resistance to many kinds of antibiotics, should strengthen detection of patients with multi drug resistant, to provide guidance for clinical rational drug use.